Summary by Moomoo AI
Trifolium Biopharmaceutical Co., Ltd. (Trifolium Bio-B) submitted the latest Securities Movement Monthly Report to the Hong Kong Exchanges and Clearing Limited on November 6, 2024, reporting the share changes as of October 31, 2024. The report indicates that the company's authorized/registered capital is maintained at 2,000,000,000 shares, with a par value of $0.0001 per share, totaling $200,000, with no changes this month. The issued shares (excluding treasury shares) increased from 1,297,054,929 shares last month to 1,297,057,929 shares, adding 3,000 common shares. This increase resulted from the exercise of pre-emptive rights before the initial public offering, with total proceeds from the exercised options this month amounting to 0 Hong Kong dollars. The company confirms that all securities issuance, treasury stock sales, or transfers have been formally authorized by the Board of Directors and comply with all applicable listing rules, laws, and other regulatory requirements.
